Doro Mind is a public benefit corporation that provides compassionate, accessible support for individuals recovering from psychosis and their families. The company offers a team-based, personalized care model that emphasizes expert clozapine management, family involvement, and long-term recovery. It aims to fill critical gaps in post-hospitalization support and care navigation for conditions like schizophrenia, schizoaffective disorder, and bipolar-1.
Company Values
The company is distinguished by its founder-driven mission, stemming from personal family experiences with psychosis recovery, and its specialized focus on a slow, expert-led clozapine titration protocol developed by its Medical Director, Dr. Robert Laitman. Its public benefit structure legally embeds its mission to prioritize patient recovery.